Search results
FDA still skeptical of ALS drug ahead of high-stakes meeting
Associated Press via Yahoo News· 2 years agoFederal health regulators remain unconvinced about the benefits of a closely watched experimental...
Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle
Investor's Business Daily· 1 year agoIntercept Pharmaceuticals said Friday its experimental liver disease treatment will face a Food and...
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug
Associated Press via AOL· 3 months agoFederal regulators put off a decision on whether to approve an Eli Lilly Alzheimer’s drug by making...
6 Things You Need to Know About Psychedelics
The Oprah Magazine via Yahoo News· 1 year ago6 Things You Need to Know About PsychedelicsKateryna Kovarzh - Getty Images Psychedelics, such as LSD and mushrooms, are expanding beyond their...
BridgeBio sells partial rights to dwarfism drug for $100M
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: BridgeBio Pharma is selling partial rights to an experimental drug for a common form of...
Notre Dame reports 75 lab mice died after dose doubled in drug research. Feds alerted.
South Bend Tribune via Yahoo News· 3 months agoA total of 75 mice died in a research lab at the University of Notre Dame after research staff...
Alzheimer's drug trials target older Californians. Do they understand what they're signing up for?
LA Times via Yahoo News· 11 months agoA gold rush in Alzheimer's pharmaceutical research raises questions about whether aging seniors...
ALS patients contend with $158K price tag on new drug
Associated Press via Yahoo News· 2 years agoFor two years, Becky Mourey pushed the Food and Drug Administration to approve an experimental drug...
Obesity drug from Boehringer, Zealand succeeds in MASH trial
BioPharma Dive via Yahoo Finance· 4 months agoZealand shares rose by more than one-third on the data, which provide further evidence so-called...
FTC, in unusual move, leads Sanofi to terminate a drug research deal
BioPharma Dive via Yahoo Finance· 6 months agoJust before clearing Pfizer’s buyout of Seagen, the regulator threatened to block Sanofi’s licensing...